Bright Minds Biosciences
DRUG
#8838
Rank
A$0.32 B
Marketcap
A$32.88
Share price
-6.22%
Change (1 day)
-63.76%
Change (1 year)

Annual Reports (40-F)

Latest form 40-F annual reports for Bright Minds Biosciences CIK: 0001827401
The 40-F is the annual report that Canadian companies file with the SEC instead of a 10-K. It contains the annual information form, MD&A and financial statements of Bright Minds Biosciences

Thumbnail Bright Minds Biosciences 40-F Annual Report 2025

40-F Annual Report 2025

Language: English

View Annual Report (40-F)